SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001387131-12-001477
Filing Date
2012-05-11
Accepted
2012-05-11 09:37:32
Documents
11
Period of Report
2012-03-31

Document Format Files

Seq Description Document Type Size
1 QUARTERLY REPORT ohrp-10q_033112.htm 10-Q 356704
2 CERTIFICATION OF CHIEF EXECUTIVE OFFICER ex-31_1.htm EX-31.1 15906
3 CERTIFICATION OF INTERIM CHIEF FINANCIAL OFFICER ex-31_2.htm EX-31.2 14638
4 CERTIFICATION OF CHIEF EXECUTIVE OFFICER ex-32_1.htm EX-32.1 6493
5 CERTIFICATION OF ITERIM CHIEF FINANCIAL OFFICER ex-32_2.htm EX-32.2 6720
  Complete submission text file 0001387131-12-001477.txt   1613613

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT ohrp-20120331.xml EX-101.INS 153675
7 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT ohrp-20120331.xsd EX-101.SCH 14101
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT ohrp-20120331_cal.xml EX-101.CAL 28557
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT ohrp-20120331_def.xml EX-101.DEF 7357
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT ohrp-20120331_lab.xml EX-101.LAB 109408
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT ohrp-20120331_pre.xml EX-101.PRE 69843
Mailing Address 1245 BRICKYARD RD #590 SALT LAKE CITY, UT 84106
Business Address 1245 BRICKYARD RD #590 SALT LAKE CITY, UT 84106 347-753-4389
Ohr Pharmaceutical Inc (Filer) CIK: 0001173281 (see all company filings)

IRS No.: 133709558 | Fiscal Year End: 0930
Type: 10-Q | Act: 34 | File No.: 333-88480 | Film No.: 12832388
SIC: 2834 Pharmaceutical Preparations